{"disease":{"id":"neurogenic-orthostatic-hypotension","name":"neurogenic orthostatic hypotension"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02586623","title":"Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":453,"lead_sponsor_name":"H. Lundbeck A/S","has_results":true},{"nct_id":"NCT03829657","title":"Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":203,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT03750552","title":"Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT04095793","title":"Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":110,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT05295810","title":"Hypercapnia in Orthostatic Hypotension","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT05489575","title":"CPAP for the Treatment of Supine Hypertension","phase":"NA","overall_status":"RECRUITING","enrollment_count":59,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT03350659","title":"Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT02705755","title":"TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT04620382","title":"Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":31,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT04782830","title":"Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms","phase":"NA","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT06751888","title":"Controlled CO2 Inhalation in NOH","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT03229174","title":"Brain Perfusion & Oxygenation in Parkinson's Disease With NOH","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"William Ondo, MD","has_results":false},{"nct_id":"NCT07089043","title":"A Study in Subjects With Neurogenic Orthostatic Hypotension","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"CuraSen Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04976101","title":"Sinusoidal Galvanic Vestibular Stimulation for Neurogenic Orthostatic Hypotension / Syncope","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Hackensack Meridian Health","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}